
Medicine overview
Indications of Adrebloc 100 mg/10 ml
Dosage of Adrebloc 100 mg/10 ml
Interaction of Adrebloc 100 mg/10 ml
Contraindications
Side Effects of Adrebloc 100 mg/10 ml
Precautions & Warnings
Storage Conditions
Drug Classes
Mode Of Action
Pregnancy
Pediatric Uses
Frequently Asked Questions
What is Adrebloc 100 mg/10 ml used for?
Adrebloc 100 mg/10 ml is a beta adrenergic blocker indicated for the short-termtreatment of: Control of ventricular rate in supraventricular tachycardia including atrial fibrillation and atrial flutter and control of heart rate in noncompensatory sinus tachycardia. Control of perioperative tachycardia and hypertension.
What is the dosage of Adrebloc 100 mg/10 ml?
Administer intravenously. Titrate using ventricular rate or blood pressure at ≥4 minute intervals. Supraventricular tachycardia (SVT) or noncompensatory sinus tachycardia- Optional loading dose: 500 mcg per kg infused over one minute Then 50 mcg per kg per minute for the next 4 minutes Adjust dose as needed to a maximum of 200 mcg per kg per minute Additional loading doses may be administered Peri…
What are the side effects of Adrebloc 100 mg/10 ml?
Most common adverse reactions (incidence> 10%) are symptomatic hypotension (hyperhidrosis, dizziness) and asymptomatic hypotension.
Who should not take Adrebloc 100 mg/10 ml?
Severe sinus bradycardia Heart block greater than first degree Sick sinus syndrome Decompensated heart failure Cardiogenic shock Coadministration of IV cardiodepressant calcium-channel antagonists (e.g. verapamil) in close proximity to Esmolol hydrochloride Pulmonary hypertension Known hypersensitivity to esmolol
What precautions should be taken with Adrebloc 100 mg/10 ml?
Risk of hypotension, bradycardia, and cardiac failure: Reduce or discontinue use Risk of exacerbating reactive airway disease Diabetes mellitus: Increases the effect of hypoglycemic agents and masks hypoglycemic tachycardia Risk of unopposed alpha-agonism and severe hypertension in untreated pheochromocytoma Risk of myocardial ischemia when abruptly discontinued in patients with coronary artery di…
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.